Abstract Details

Title Long-Term Maintenance of Efficacy with Retigabine 600-1200 mg/Day in Adult Patients with Refractory Epilepsy: Extension Study of RESTORE 1

Topic Epilepsy

Presentation(s) (-)

Poster/Presentation
Number 193

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Rachel Ventura, MD	No disclosure on file
William E. Rosenfeld, MD, FAAN (Comprehensive Epilepsy Care Center for Children and Adults)	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.
Gabriel Vidal, MD	Dr. Vidal has nothing to disclose.

��ɫ��